Cai X.D., Che L., Lin J.X., Huang S., Li J., Liu X.Y., Pan X.F., Wang Q.Q., Chen L., Lin M.J., Huang Z.H., Ma H.M., Wu Y., Liu S.M, & Zhou Y.B. (2017). Krüppel-like factor 17 inhibits urokinase plasminogen activator gene expression to suppress cell invasion through the Src/p38/MAPK signaling pathway in human lung adenocarcinoma. Oncotarget, 8(24), 38743-38754.
Anti antibodies Gapdh Human P38 mapk P44 mapkWestern blot
Corresponding Organization :
Other organizations :
First Affiliated Hospital of Jinan University, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Jinan University, Third Affiliated Hospital of Guangzhou Medical University, The First Affiliated Hospital, Sun Yat-sen University, Sun Yat-sen University
Anti-human KLF17 antibody (1:200, Santa Cruz, CA; 1:200, Sigma, CA)
Anti-uPA antibody (1:200, Sigma, CA)
Anti-Phospho-p38/MAPK antibody
Anti-Phospho-pERK1/2 antibody
Anti-Phospho-pSAPK/JNK antibody
Anti-Phospho-Akt antibody
Anti-Phospho-p44/42/MAPK antibody
Anti-Phospho-PI3-Kinasep85 antibody
Anti-Phospho-Src (Tyr527) antibody
dependent variables
Protein expression levels of KLF17, uPA, Phospho-p38/MAPK, Phospho-pERK1/2, Phospho-pSAPK/JNK, Phospho-Akt, Phospho-p44/42/MAPK, Phospho-PI3-Kinasep85, and Phospho-Src (Tyr527)
control variables
Anti-GAPDH antibody (Bioworld Tech, Inc., Nanjing, China) as an internal control
controls
Positive control: Not specified
Negative control: Not specified
Annotations
Based on most similar protocols
Etiam vel ipsum. Morbi facilisis vestibulum nisl. Praesent cursus laoreet felis. Integer adipiscing pretium orci. Nulla facilisi. Quisque posuere bibendum purus. Nulla quam mauris, cursus eget, convallis ac, molestie non, enim. Aliquam congue. Quisque sagittis nonummy sapien. Proin molestie sem vitae urna. Maecenas lorem.
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to
get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
